Ozempic is a popular injectable medication that has gained attention worldwide, especially for managing type 2 diabetes and aiding weight loss. Its active ingredient, semaglutide, belongs to a class ...
Lilly (LLY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Children and teens with type 2 diabetes are more likely to receive insulin than newer GLP-1 receptor agonists, according to a new study published in Pediatrics. Current guidelines from the American ...
Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...
Poison control said last year it averaged one to two calls a day about GLP-1 drugs with 80 percent of those calls involving a mistake when administering the drug.
With close to one million downloads, Shotsy is the most popular GLP-1 tracking app on the market, and now meets patients at every stage of their GLP-1 journey.
GLP-1 receptor agonists hold key market opportunities due to their effectiveness in diabetes and obesity management, ...
India Today on MSN
New weight-loss pill beats oral Wegovy in major trial
A once-daily experimental GLP-1 pill shows greater weight loss and blood sugar control than current oral options, and could soon reshape obesity and diabetes care.
All 16 of the drug manufacturers that signed deals with Trump have issued price hikes this year, according to reports.
Lev Facher covers the U.S. addiction and overdose crisis. ROCHESTER, N.H. — Megan Merrill paused, mid-hike, as she surveyed the steep drop before her. She was standing on a five-foot snow drift, icy ...
The primary difference between the Wegovy pill and the injection is how you take them and how often. The Wegovy pill is a daily tablet you swallow, while the Wegovy injection is a once-weekly shot you ...
A Columbus Division of Police detective was contacted on Feb. 6 by staff at Nationwide Children’s about a mother accused of abusing her child, our news partners at WBNS reported. The child was a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results